Cargando…

The oncogenic role of the In1-ghrelin splicing variant in prostate cancer aggressiveness

BACKGROUND: The Ghrelin-system is a complex, pleiotropic family composed of several peptides, including native-ghrelin and its In1-ghrelin splicing variant, and receptors (GHSR 1a/b), which are dysregulated in various endocrine-related tumors, where they associate to pathophysiological features, but...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hormaechea-Agulla, Daniel, Gahete, Manuel D., Jiménez-Vacas, Juan M., Gómez-Gómez, Enrique, Ibáñez-Costa, Alejandro, L-López, Fernando, Rivero-Cortés, Esther, Sarmento-Cabral, André, Valero-Rosa, José, Carrasco-Valiente, Julia, Sánchez-Sánchez, Rafael, Ortega-Salas, Rosa, Moreno, María M., Tsomaia, Natia, Swanson, Steve M., Culler, Michael D., Requena, María J., Castaño, Justo P., Luque, Raúl M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576296/ https://www.ncbi.nlm.nih.gov/pubmed/28851363 http://dx.doi.org/10.1186/s12943-017-0713-9

Ejemplares similares

Oncogenic Role of Secreted Engrailed Homeobox 2 (EN2) in Prostate Cancer
por: Gómez-Gómez, Enrique, et al.
Publicado: (2019)

Plasma ghrelin O‐acyltransferase (GOAT) enzyme levels: A novel non‐invasive diagnosis tool for patients with significant prostate cancer
por: Gómez‐Gómez, Enrique, et al.
Publicado: (2018)

In1-ghrelin splicing variant is overexpressed in pituitary adenomas and increases their aggressive features
por: Ibáñez-Costa, Alejandro, et al.
Publicado: (2015)

Clinical Utility of Ghrelin-O-Acyltransferase (GOAT) Enzyme as a Diagnostic Tool and Potential Therapeutic Target in Prostate Cancer
por: Jiménez-Vacas, Juan M., et al.
Publicado: (2019)

In1-ghrelin, a splice variant of ghrelin gene, is associated with the evolution and aggressiveness of human neuroendocrine tumors: Evidence from clinical, cellular and molecular parameters
por: Luque, Raul M., et al.
Publicado: (2015)

A Novel Human Ghrelin Variant (In1-Ghrelin) and Ghrelin-O-Acyltransferase Are Overexpressed in Breast Cancer: Potential Pathophysiological Relevance
por: Gahete, Manuel D., et al.
Publicado: (2011)

Unleashing the Diagnostic, Prognostic and Therapeutic Potential of the Neuronostatin/GPR107 System in Prostate Cancer
por: Sáez-Martínez, Prudencio, et al.
Publicado: (2020)

Ghrelin-O-Acyltransferase (GOAT) Enzyme as a Novel Potential Biomarker in Gastroenteropancreatic Neuroendocrine Tumors
por: Herrera-Martínez, Aura D., et al.
Publicado: (2018)

Clinical association of metabolic syndrome, C‐reactive protein and testosterone levels with clinically significant prostate cancer
por: Gómez‐Gómez, Enrique, et al.
Publicado: (2018)

Obesity and metabolic dysfunction severely influence prostate cell function: role of insulin and IGF1
por: L‐López, Fernando, et al.
Publicado: (2017)

Role of Endogenous Cortistatin in the Regulation of Ghrelin System Expression at Pancreatic Level under Normal and Obese Conditions
por: Chanclón, Belén, et al.
Publicado: (2013)

Sarcopenia and Ghrelin System in the Clinical Outcome and Prognosis of Gastroenteropancreatic Neuroendocrine Neoplasms
por: Herrera-Martínez, Yiraldine, et al.
Publicado: (2021)

Observational study comparing the accuracy/variability between the ERSPC and the PCPT risk calculators for the prediction of significant prostate cancer in patients with PSA <10 ng/mL
por: Gomez Gomez, Enrique, et al.
Publicado: (2019)

CE–MS-based urinary biomarkers to distinguish non-significant from significant prostate cancer
por: Frantzi, Maria, et al.
Publicado: (2019)

SF3B1 inhibition disrupts malignancy and prolongs survival in glioblastoma patients through BCL2L1 splicing and mTOR/ß-catenin pathways imbalances
por: Fuentes-Fayos, Antonio C., et al.
Publicado: (2022)

Dysregulation of the miRNome unveils a crosstalk between obesity and prostate cancer: miR-107 asa personalized diagnostic and therapeutic tool
por: Herrero-Aguayo, Vicente, et al.
Publicado: (2022)

Common Sources of Inflammation and Their Impact on Hematopoietic Stem Cell Biology
por: Hormaechea-Agulla, Daniel, et al.
Publicado: (2020)

Comparative Cytotoxic Activity of Hydroxytyrosol and Its Semisynthetic Lipophilic Derivatives in Prostate Cancer Cells
por: León-González, Antonio J., et al.
Publicado: (2021)

THU550 The Splicing Factor SRSF6 Regulates Androgen Receptor Activity And Represents A Potential Therapeutic Target In Prostate Cancer
por: Luque, Raul M, et al.
Publicado: (2023)

Dysregulation of the splicing machinery is directly associated to aggressiveness of prostate cancer
por: Jiménez-Vacas, Juan M., et al.
Publicado: (2020)

New Insights into the Role of E2s in the Pathogenesis of Diseases: Lessons Learned from UBE2O
por: Hormaechea-Agulla, Daniel, et al.
Publicado: (2018)

Presence of sst5TMD4, a truncated splice variant of the somatostatin receptor subtype 5, is associated to features of increased aggressiveness in pancreatic neuroendocrine tumors
por: Sampedro-Núñez, Miguel, et al.
Publicado: (2015)

Adipokines (Leptin, Adiponectin, Resistin) Differentially Regulate All Hormonal Cell Types in Primary Anterior Pituitary Cell Cultures from Two Primate Species
por: Sarmento-Cabral, André, et al.
Publicado: (2017)

The truncated somatostatin receptor sst5TMD4 stimulates the angiogenic process and is associated to lymphatic metastasis and disease-free survival in breast cancer patients
por: Gahete, Manuel D., et al.
Publicado: (2016)

Role of Multiparametric Prostate Magnetic Resonance Imaging before Confirmatory Biopsy in Assessing the Risk of Prostate Cancer Progression during Active Surveillance
por: Salguero, Joseba, et al.
Publicado: (2021)

Metformin and simvastatin exert additive antitumour effects in glioblastoma via senescence-state: clinical and translational evidence
por: Fuentes-Fayos, Antonio C., et al.
Publicado: (2023)

Somatostatin Receptor Splicing Variant sst5TMD4 Overexpression in Glioblastoma Is Associated with Poor Survival, Increased Aggressiveness Features, and Somatostatin Analogs Resistance
por: Fuentes-Fayos, Antonio C., et al.
Publicado: (2022)

Palliative Surgery for Rare Cases of Anterior Urethral Metastasis in Prostate Cancer
por: Gómez Gómez, Enrique, et al.
Publicado: (2014)

Somatostatin, Cortistatin and Their Receptors Exert Antitumor Actions in Androgen-Independent Prostate Cancer Cells: Critical Role of Endogenous Cortistatin
por: Sáez-Martínez, Prudencio, et al.
Publicado: (2022)

Lack of cortistatin or somatostatin differentially influences DMBA-induced mammary gland tumorigenesis in mice in an obesity-dependent mode
por: Luque, Raúl M., et al.
Publicado: (2016)

In Situ Localization and Rhythmic Expression of Ghrelin and ghs-r1 Ghrelin Receptor in the Brain and Gastrointestinal Tract of Goldfish (Carassius auratus)
por: Sánchez-Bretaño, Aída, et al.
Publicado: (2015)

Splicing machinery dysregulation drives glioblastoma development/aggressiveness: oncogenic role of SRSF3
por: Fuentes-Fayos, Antonio C, et al.
Publicado: (2020)

Prostate Cancer Patients–Negative Biopsy Controls Discrimination by Untargeted Metabolomics Analysis of Urine by LC-QTOF: Upstream Information on Other Omics
por: Fernández-Peralbo, M. A., et al.
Publicado: (2016)

Breast cancer is associated to impaired glucose/insulin homeostasis in premenopausal obese/overweight patients
por: Luque, Raúl M., et al.
Publicado: (2017)

THU080 Splicing Machinery Dysregulation As A Source Of Novel Diagnostic, Prognostic And Therapeutic Targets In Craniopharyngiomas
por: Fuentes-Fayos, Antonio C, et al.
Publicado: (2023)

SUN-LB056 The Pharmacological Blockade of the Splicing Factor SF3B1 Exerts Antitumor Actions in Different Endocrine-Related Cancers
por: Gahete, Manuel, et al.
Publicado: (2019)

The Truncated Isoform of Somatostatin Receptor5 (sst5TMD4) Is Associated with Poorly Differentiated Thyroid Cancer
por: Puig-Domingo, Manel, et al.
Publicado: (2014)

Obesity- and gender-dependent role of endogenous somatostatin and cortistatin in the regulation of endocrine and metabolic homeostasis in mice
por: Luque, Raúl M., et al.
Publicado: (2016)

Ghrelin Indirectly Activates Hypophysiotropic CRF Neurons in Rodents
por: Cabral, Agustina, et al.
Publicado: (2012)

Ghrelin
por: Müller, T.D., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_2bhp88o7j0pjd0j688u14b70ft